Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Health Phys. 2018 Jul;115(1):65–76. doi: 10.1097/HP.0000000000000841

Fig 1.

Fig 1

Survival of CD2F1 mice following total body irradiation with 9.35 Gy at the estimated rate of 0.6 Gy min−1and administered a single dose of BBT-059 at 0.3 mg kg−1 (solid line) or formulation buffer (10 mM sodium phosphate, 4% mannitol, 1% sucrose, pH 6.2) as vehicle (dashed line). BBT-059 was administered either 24 h prior to TBI (A), 4 h post-TBI (B) or 24 h post-TBI (C). Kaplan-Meier survival curves were plotted using GraphPad software; n=24 mice per group and trend in survival is compared between vehicle and drug-treated groups (Log-rank test p <0.0001 – 0.0005).